Background Carcinoembryonic antigen is the commonly used tumor marker in patients with
colorectal cancer, and CA 19-9 might be an additional marker. The aim of this retrospective …

The aim of the present study was to investigate the value of combined detection of serum
carcino‑embryonic antigen (CEA), carbohydrate antigen (CA) 19‑9 and cyclooxygenase‑2 …

Abstract Background and Objectives Carcinoembryonic antigen (CEA) and carbohydrate
antigen (CA19‐9) are well known to be the most common tumor markers of colorectal …

Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA19-9) are well known tumor
markers expressed by colorectal cancer (CRC), particularly in advanced cases. In this study …

Serum carcinoembryonic antigen (CEA) and CA19‐9, a carbohydrate antigen recognized by
the monoclonal antibody NS19‐9, are commonly used as classical tumor markers in …

Colorectal cancer (CRC), the second most fatal cancer and the 3rd most common cancer is
expected to cause 0.9 million deaths globally in 2025. Carcinoembryonic antigen (CEA) is …

In clinical practice, colorectal cancer (CRC) is difficult to distinguish from ulcerative colitis
and colon polyps. Practical markers are useful for diagnosing and treating patients with …

Aims: This study evaluated the prognostic value of the preoperative CEA and CA 19-9 levels
on the survival time and TNM staging in patients with colorectal cancer. Methodology: We …

Preoperative CEA and CA 19–9 levels have been used in the past as prognostic indicators
in colorectal cancer, but Dukes' stage is still considered to be the most important prognostic …

The precise preoperative staging of colorectal cancer is fundamental for surgical strategy,
incomplete staging means incomplete treatment and poor outcome. Large-scale clinical …